# Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx

> **NCT00843635** · NA · COMPLETED · sponsor: **Donald T. Weed** · enrollment: 35 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Tadalafil
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00843635
- **Lead sponsor:** Donald T. Weed
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2015-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00843635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00843635, "Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00843635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*